Mercer Global Advisors
XERS icon

Mercer Global Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Mercer Global Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
28,510
+11,522
+68% +$73.6K ﹤0.01% 3123
2026
Q1 		$98.5K Buy
+16,988
New +$113K ﹤0.01% 3021
2025
Q4 		– Sell
-10,466
Closed -$85.2K – 2974
2025
Q3 		$85.2K Buy
+10,466
New +$69.5K ﹤0.01% 2543

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mercer Global Advisors's XERS Position: Q2 2026 in Review

Mercer Global Advisors increased its Xeris Biopharma Holdings (XERS) stake by 68% in Q2 2026, buying an estimated $73.6K and bringing the position to 28,510 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

Mercer Global Advisors first reported a position in XERS in Q3 2025 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Mercer Global Advisors held 28,510 shares of Xeris Biopharma Holdings worth $226K as of Q2 2026.
  • Mercer Global Advisors bought 11,522 Xeris Biopharma Holdings shares in Q2 2026, an estimated $73.6K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3123 holding.
  • Mercer Global Advisors first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.